Skip to main content
Journal of Feline Medicine and Surgery logoLink to Journal of Feline Medicine and Surgery
. 2011 Aug 1;13(8):553–557. doi: 10.1016/j.jfms.2011.03.006

Prevalence of Bartonella species, haemoplasmas and Toxoplasma gondii in cats in Scotland

Alexander D Bennett 1,*, Danielle A Gunn-Moore 2, Melissa Brewer 1, Michael R Lappin 1
PMCID: PMC10822398  PMID: 21570883

Abstract

The objective of this study was to determine the prevalence rates for select infectious agents of cats presented to the Royal (Dick) School of Veterinary Studies at the University of Edinburgh, Scotland. Whole blood, serum, and oral mucosal and nail bed swabs were collected. While Ehrlichia species, Anaplasma species or Rickettsia felis DNA were not amplified from any cat, 44.2% of the cats had evidence of infection or exposure to either a Bartonella species (15.3% were seropositive and 5.8% polymerase chain reaction (PCR) positive), a haemoplasma (28.6% PCR positive), and/or Toxoplasma gondii (19.2% seropositive). No Bartonella species DNA was amplified from the nail or oral mucosal swabs despite a 5.8% amplification rate from the blood samples. This finding likely reflects the absence of Ctenocephalides felis infection from our study population, as this organism is a key component for Bartonella species translocation in cats. The results from this study support the use of flea control products to lessen exposure of cats (and people) to Bartonella species and support discouraging the feeding of raw meat to cats and preventing them from hunting to lessen T gondii infection.


There are many infectious agents that can cause morbidity and mortality in cats. Several organisms that infect cats are also zoonotic, for example, the flea-borne pathogens Bartonella species and Rickettsia felis and the coccidian parasite Toxoplasma gondii. In addition, the feline haemoplasmas, Ehrlichia species, and Anaplasma phagocytophilum are known to infect cats and are potentially important causes of disease in this species. 1

Cats are the only known definitive host for T gondii and they perpetuate the organism in the environment by shedding oocysts. Transplacental infection of human fetuses as well as systemic infection of immunocompromised people can result in significant illness in humans. While T gondii seropositive cats have been detected in the United Kingdom, 2,3 the current seroprevalence rates in cats in Scotland are unknown.

Ctenocephalides felis carry haemoplasmas, several Bartonella species and R felis. 4 Cats are the reservoir for several Bartonella species that are associated with illness in people including Bartonella henselae, Bartonella clarridgeaie and Bartonella koehlerae. 5 Disease manifestations in people are diverse and include cat scratch disease, bacillary peliosis, bacillary angiomatosis and a variety of other chronic illnesses. 6,7 Rickettsia felis can induce a mild spotted fever syndrome in humans. 8 The haemotropic mycoplasmas (Mycoplasma haemofelis, ‘Candidatus M haemominutum, and ‘Candidatus M turicensis’) have been detected in cats of the UK. 9 While C felis is known to exist in the UK and has been shown to carry R felis and B henselae, 4 it is currently unknown how many cats in Scotland have been exposed to or are carriers of these agents.

The tick-borne infectious agents, Ehrlichia species, A phagocytophilum and R felis have been documented in cats from other countries in western Europe. 10 Ixodes species ticks are the vectors of A phagocytophilum, and these ticks have been documented in the UK; in addition, the vole may be a competent reservoir for A phagocytophilum. 10 Whether these agents are common in cats in Scotland is currently unknown.

Determination of prevalence rates for these infectious agents in cats living in Scotland would be useful for predicting the likelihood of infection in cats presenting with appropriate clinical signs as well as for assessing for potential zoonotic risks. Furthermore, there is little information available concerning numbers of naturally exposed cats that have the DNA of these organisms residing on the nail beds and gingival mucosa. Data on this are important as these are likely means of transmission of infectious disease between cats and to the human population. Lastly, with the increased use of therapeutic blood products in cats, determining the regional occurrence of these blood-borne agents could be useful in the development of optimal screening protocols. 1113 The aim of this prospective study was to determine the prevalence of Bartonella species, R felis, haemoplasmas, Ehrlichia species, A phagocytophilum and T gondii from companion and shelter cats residing in Scotland.

Materials and methods

Cats

Samples were collected from cats presenting to the Hospital for Small Animals at the Royal (Dick) School of Veterinary Studies (RDSVS) between June and August 2009. Blood was being collected for routine investigation of clinical disease or, in the case of stray cats from charity organisations, for health screening prior to re-homing. Information regarding the use of a flea and tick preventative was gathered from each owner, or the shelter supervisor, prior to sample collection. Informed owner consent was obtained in all cases and the study was approved by the Veterinary Ethics and Research Committee of the RDSVS.

Samples

Blood samples were obtained by jugular venepuncture and once aliquots were removed for their primary analyses, any remaining blood was placed in serum separator and/or EDTA KE/2-containing plastic tubes. Samples from the oral mucosa and nail beds were collected using sterile cotton-tipped bacterial culture swabs. The swabs were soaked in 200 μl of phosphate buffered saline solution before collection. Swabs were rubbed vigorously on the base of the right maxillary canine tooth and from the nail beds of digits 3 and 4 of the right forepaw. 5 All samples were stored at −20°C until being shipped on ice packs to Colorado State University. Upon arrival the samples were stored at −70°C until assayed.

Assays

After being thawed at room temperature, total DNA was extracted from swabs and blood samples and prepared for polymerase chain reaction (PCR) assays using commercially available reagents as previously described. 5 PCR assays that amplify the DNA of Ehrlichia, Neorickettsia, and Anaplasma species, Rickettsia species, haemoplasmas, the DNA of six Bartonella species, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (DNA control) were performed on each extract. 1,1316 Samples negative for GAPDH were excluded from the analysis. Positive and negative controls were assessed with all PCR assays using the previously published assays and standard operating procedures of the Center for Companion Animal Studies (http://csuvets.colostate.edu/companion/index.htm).

Most of the Bartonella species give a different amplicon size and these sizes are used to determine the species present in the sample. However, B henselae and B koehlerae DNA are within the same amplicon and so all positive samples were confirmed by genetic sequencing using a commercially available service (Macro-molecular Resources, Colorado State University, Fort Collins, CO 80523). In the haemoplasma PCR assay, DNA of both M haemofelis and ‘Candidatus M turicensis’ are within the same amplicon and so when sufficient DNA was available these amplicons were sequenced to determine the infective species.

Bartonella species antibody titres were determined by enzyme-linked immunosorbent assay (ELISA) as previously described. 5 Titres equal to or greater than 1:64 were considered seroreactive. For T gondii, IgM and IgG antibodies were determined by ELISA as previously described. 17 For both IgM and IgG, antibody titres equal to or greater than 1:64 were considered seroreactive.

Statistical analysis

Fisher's exact test was used to compare prevalence rates between some groups of results. Statistical significance was defined as P<0.05.

Results

A total of 78 cats were entered into the study. Of the cats, 61 were client-owned and 17 were from rescue centres; 40 were clinically ill and 38 were considered healthy. Disease manifestations varied and were not specific for any infectious agent associated syndrome. The age ranges for the cats were <1 (three cats); 1–3 years (22 cats), 4–6 years (14 cats), 7–9 (12 cats), 10–12 (11 cats), >13 (16 cats). The study population included intact male cats (three), neutered male cats (42), spayed female cats (27), and intact female cats (six). Of the cats, 23 (29.5%) were currently on a flea or tick preventative at the time of sample collection. Fleas or flea dirt were not found on any of the cats on physical examination. All samples were not available from all sites in every case. This varied based on whether remnant blood samples were available (blood and serum) and on the temperament of the cat (mouth and nail bed swabs).

DNA of Ehrlichia species, A phagocytophilum or R felis were not amplified from any sample.

Bartonella species antibodies were detected in 8/52 sera (15.3%) and Bartonella species DNA was amplified from 3/52 blood samples (5.8%). All Bartonella species PCR positive cats were seropositive and each of the species was B henselae. None of the PCR positive or seropositive cats in this group were on a flea preventative. Bartonella species DNA was not amplified from oral mucosal (n=71) or nail bed swabs (n=71) from any of the cats in the study, including the three cats that were positive for Bartonella henselae DNA in blood.

The haemoplasma PCR assay was performed on 63 oral mucosal swabs, nail bed swabs and blood samples. None of the nail bed swabs were positive for haemoplasma DNA. DNA of one or more haemoplasmas was amplified from 9/63 (14.3%) of the blood samples. ‘Candidatus M haemominutum’ DNA was the only haemoplasma amplified from the blood of six cats. DNA of ‘Candidatus M haemominutum’ and M haemofelis/Candidatus M turicensis were amplified concurrently from the blood of two cats; one of these amplicons was confirmed as M haemofelis by sequencing and the other amplicon could not be sequenced.

From oral mucosal swabs, five cats were positive for the DNA of one or more haemoplasma. DNA of M haemofelis alone was amplified from one cat and DNA of both M haemofelis and ‘Candidatus M haemominutum’ were amplified from three cats. Sequencing from one sample that was PCR positive for both revealed M haemofelis 16S rRNA gene and ‘Candidatus M haemominutum’ strain IT23 with 80% and 82% homology, respectively. There was insufficient DNA available for sequencing the remaining four PCR positive samples. Of the five oral swabs that were PCR positive for either M haemofelis or ‘Candidatus M haemominutum’, PCR on the blood was found to be positive (two cats), negative (two cats) or not available (one cat).

The proportions of cats positive for haemoplasma DNA were compared between client-owned and shelter cats (Table 1) and between normal and clinically ill cats (Table 2). Shelter cats were more likely than client-owned cats to have the DNA of any haemoplasma in blood (P=0.028), M haemofelis DNA alone in the blood (P=0.023), and DNA of both M haemofelis and ‘Candidatus M haemominutum’ from oral swab samples (P=0.044). Healthy cats were more likely than clinically ill cats to have DNA of any haemoplasma species in the blood (P=0.031).

Table 1.

Select infectious agent test results stratified by the source of cats in Scotland.

Total positive Shelter Client P value
Any Bartonella species test positive 8/52 (15.4%) 2/10 (20%) 6/42 (14.3%) 0.6415
Bartonella species serology 8/52 (15.4%) 2/10 (20%) 6/42 (14.3%) 0.6415
B henselae PCR 3/52 (5.8%) 0/10 (0%) 3/42 (7.1%) 0.6226
T gondii serology 10/52 (19.2%) 2/10 (20%) 8/42 (19.0%) 1
Any haemoplasma in blood 9/63 (14.3%) 4/10 (40%) 5/53 (9.4%) 0.0288
Mhm alone 7/63 (11.1%) 2/10 (20%) 5/53 (9.4%) 0.3065
Mhf alone 2/63 (3.2%) 2/10 (20%) 0/53 (0%) 0.023
Any haemoplasma swab 5/60 (7.0%) 3/15 (20%) 2/45 (4.4%) 0.0943
Mhf alone 1/60 (1.4%) 0/15 (0%) 1/45 (2.2%) 1
Mhf and Mhm 4/60 (5.6%) 3/15 (20%) 1/45 (2.2%) 0.0448

Mhf= Mycoplasma haemofelis; Mhm=‘Candidatus M haemominutum’; swab=DNA collected from the base of the canine tooth or claw bed.

Table 2.

Select infectious agent test results stratified by the clinical status of the cats evaluated in Scotland.

Total positive Healthy Clinically ill P value
Any Bartonella species test positive 8/52 (15.4%) 3/26 (11.5%) 5/26 (19.2%) 0.703
Bartonella species serology 8/52 (15.4%) 3/26 (11.5%) 5/26 (19.2%) 0.703
B henselae PCR 3/52 (5.8%) 0/26 (0%) 3/26 (11.5%) 0.238
T gondii serology 10/52 (19.2%) 5/26 (19.2%) 5/26 (19.2%) 1
Any haemoplasma in blood 9/63 (14.3%) 7/27 (25.9%) 2/36 (5.5%) 0.0312
Mhm alone 7/63 (11.1%) 5/27 (18.5%) 2/36 (5.5%) 0.1279
Mhf alone 2/63 (3.2%) 2/27 (7.4%) 0/36 (0%) 0.1797
Any haemoplasma swab 5/60 (7.0%) 5/35 (14.2%) 0/25 (0%) 0.1474
Mhf alone 1/60 (1.4%) 1/35 (2.8%) 0/25 (0%) 1
Mhf and Mhm 4/60 (5.6%) 4/35 (11.4%) 0/25 (0%) 0.1333

Mhf= Mycoplasma haemofelis; Mhm = ‘Candidatus M haemominutum’; swab=DNA collected from the base of the canine tooth or claw bed.

Overall, 10/52 cats (19.2%) were seropositive for T gondii species in serum. IgG alone (five cats), IgM alone (four cats), or both antibodies (one cat) were detected.

Discussion

All serological tests and PCR assays were performed on blood or serum samples from 52 cats, of which 23 (44.2%) were positive in one or more infectious agents. The high (44%) prevalence of one or more infectious agents indicate that haemoplasmas, Bartonella species, and T gondii infections should be on the differential list for cats with appropriate clinical signs of disease. While we compared prevalence rates between cats with and without clinical illness, these results should be interpreted cautiously as the sample set is very small and the clinical diseases reported were not necessarily consistent with those associated with haemoplasmas, Bartonella species and T gondii. The failure to amplify Ehrlichia species, Anaplasma species or R felis DNA from samples from these cats may merely reflect the small sample size and larger numbers of samples from cats with appropriate clinical findings (fever, thrombocytopenia, polyarthritis) should be performed.

While Bartonella species DNA has previously been amplified from C felis collected in the UK, 4 this is the first report of Bartonella species infections in cats from Scotland. Bartonella henselae DNA was the only Bartonella species amplified from the three positive blood samples. However, additional cats were seropositive (15.3%) and the Bartonella species ELISA used can cross react with B clarridgeaie and B koehlerae antibodies. Further samples will need to be assessed by PCR to determine whether other Bartonella species exist in cats in Scotland.

Bartonella species DNA was not amplified from the nail bed or oral mucosa swabs from the cats described in this study. This finding may reflect the use of flea control products in some of the cats (29.5%) and the lack of evidence of current flea infestation in all cats. In contrast, a similar study evaluating feral cats residing in high C felis infestation areas in the United States, showed that 17.6% of 51 cats sampled had Bartonella species DNA amplified from nail bed or oral mucosal samples. 5 Bartonella species has been documented in C felis flea dirt and survives for days after passage from the flea. 18,19 Bartonella species DNA was not amplified from the oral mucosa of any cat in the current study which is likely to reflect the absence of oral cavity disease and the lack of fleas or flea dirt which can contaminate the oral cavity during grooming. It was recently shown that administration of imidacloprid blocks transmission of B henselae amongst cats. 20 As cats without fleas are unlikely to be sources of Bartonella species infections for humans, the Centers for Disease Control recommends avoiding cats bites and scratches and encourages the use of flea control products rather than testing or treating healthy cats for Bartonella species infections. 21 The Bartonella species prevalence rates described here suggest that use of flea control products is indicated in cats in Scotland.

The prevalence rates for haemoplasma species DNA in blood were similar to other studies in the region. 22 The failure to amplify ‘Candidatus M turicensis’ DNA may merely reflect the small sample size. In previous studies of experimentally infected or naturally exposed cats, haemoplasma species DNA has been amplified from fleas, flea dirt, oral mucosal swabs, saliva, and nail bed swabs. 1,5,2326 It has been documented that some haemoplasmas can be transmitted directly between cats. 25 Amplification of haemoplasma DNA from the oral mucosa of some cats described here supports the findings of that study. The failure to amplify haemoplasma DNA from nail beds in the cats in the current study probably reflects the absence of fleas or flea dirt as discussed for Bartonella species.

With increasing frequency, blood transfusions are given to anaemic and bleeding feline patients. 11,13,27 Overall, 3/52 (5.8%) and 9/63 (14.3%) of cats in this study were positive in blood for Bartonella species or haemoplasma species DNA, respectively. These results suggest that cats used as blood donors in Scotland should be maintained on flea control products and should be screened for haemoplasma species and Bartonella species infections by PCR before use. 12

Toxoplasma gondii infections have previously been reported in cats living in Scotland. 2,28 Prevalence rates for T gondii antibodies were similar to others that studied cats in similar climates. 17 In accordance with public health guidelines, limiting hunting and the feeding of raw meat to cats may indirectly lessen the human risk of exposure to this infectious agent. 21

The results from this study support the use of flea control products to lessen exposure of cats (and potentially, people) to Bartonella species and they support the recommendations to discourage the feeding of raw meat to cats and to prevent them from hunting so that the risk of them becoming infected with T gondii is reduced.

Acknowledgements

The authors would like to acknowledge Alicia Alberico for her assistance with the assay performance.

References

  • 1. Lappin M.R., Griffin B., Brunt J., et al. Prevalence of Bartonella species, haemoplasma species, Ehrlichia species, Anaplasma phagocytophilum, and Neorickettsia risticii DNA in the blood of cats and their fleas in the United States, J Feline Med Surg 8, 2006, 85–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. McConnell J.F., Sparkes A.H., Blunden A.S., Neath P.J., Sansom J. Eosinophilic fibrosing gastritis and toxoplasmosis in a cat, J Feline Med Surg 9, 2007, 82–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gethings P.M., Stephens G.L., Wills J.M., et al. Prevalence of chlamydia, toxoplasma, toxocara and ringworm in farm cats in south-west England, Vet Rec 121, 1987, 213–216. [DOI] [PubMed] [Google Scholar]
  • 4. Shaw S.E., Kenny M.J., Tasker S., Birtles R.J. Pathogen carriage by the cat flea Ctenocephalides felis (Bouché) in the United Kingdom, Vet Microbiol 102, 2004, 183–188. [DOI] [PubMed] [Google Scholar]
  • 5. Lappin M.R., Hawley J. Presence of Bartonella species and Rickettsia species DNA in the blood, oral cavity, skin and claw beds of cats in the United States, Vet Dermatol 20, 2009, 509–514. [DOI] [PubMed] [Google Scholar]
  • 6. Lappin M.R., Breitschwerdt E., Brewer M., Hawley J., Hegarty B., Radecki S. Prevalence of Bartonella species antibodies and Bartonella species DNA in the blood of cats with and without fever, J Feline Med Surg 11, 2009, 141–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Breitschwerdt E.B., Maggi R.G., Chomel B.B., Lappin M.R. Bartonellosis: an emerging infectious disease of zoonotic importance to animals and human beings, JVECCS 20, 2010, 8–30. [DOI] [PubMed] [Google Scholar]
  • 8. Reif K.E., Macalusa K.R. Ecology of Rickettsia felis: a review, J Med Entomol 46, 2009, 723–736. [DOI] [PubMed] [Google Scholar]
  • 9. Tasker S., Binns S.H., Day M.J., et al. Use of a PCR assay to assess prevalence and risk factors for Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ in cats in the United Kingdom, Vet Rec 152, 2003, 193–198. [DOI] [PubMed] [Google Scholar]
  • 10. Brown K.J., Begon M., Bennett M., et al. Sympatric Ixodes tranguliceps and Ixodes ricinus ticks feeding on field voles (Microtus agrestis): Potential for increased risk of Anaplasma phagocytophilum in the United Kingdom?, Vector-Borne Zoo Dis 6, 2006, 4. [DOI] [PubMed] [Google Scholar]
  • 11. Hackett T.B., Jensen W.A., Lehman T.L., et al. Prevalence of DNA of Mycoplasma haemofelis, ‘ Candidatus Mycoplasma haemominutum,’ Anaplasma phagocytophilum, and species of Bartonella, Neorickettsia, and Ehrlichia in cats used as blood donors in the United States, J Am Vet Med Assoc 229, 2006, 700–705. [DOI] [PubMed] [Google Scholar]
  • 12. Wardrop K.J., Reine N., Brikenheuer A., et al. Canine and feline blood donor screening for infectious disease, ACVIM Consensus Statement J Vet Intern Med 19, 2005, 135–142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Gary A.T., Richmond H.L., Tasker S., Hackett T.B., Lappin M.R. Survival of Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ in blood of cats used for transfusions, J Feline Med Surg 8, 2006, 321–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kamrani A., Parreira V.R., Greenwood J., Prescott J.F. The prevalence of Bartonella, hemoplasma, and Rickettsia felis infections in domestic cats and in cat fleas in Ontario, Can J Vet Res 72, 2008, 411–419. [PMC free article] [PubMed] [Google Scholar]
  • 15. Jensen W.A., Lappin M.R., Kamkar S., Reagan W. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats, Am J Vet Res 62, 2001, 604–608. [DOI] [PubMed] [Google Scholar]
  • 16. Jensen W.A., Fall M.Z., Rooney J., Kordick D.L., Breitschwerdt E.D. Rapid identification and differentiation of Bartonella species using a single step PCR assay, J Clin Microbiol 38, 2000, 1717–1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Hawley J.R., Shaw S.E., Lappin M.R. Prevalence of Rickettsia felis DNA in the blood of cats and their fleas in the United States, J Feline Med Surg 9, 2007, 258–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Vollaire M.R., Radecki S.V., Lappin M.R. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States, Am J Vet Res 66, 2005. May, 874–877. [DOI] [PubMed] [Google Scholar]
  • 19. Finkelstein J.L., Brown T.P., O’Reilly K.L., Wedincamp J., Jr., Foil L.D. Studies on the growth of Bartonella henselae in the cat flea, J Med Entomol 39, 2002, 915–919. [DOI] [PubMed] [Google Scholar]
  • 20. Higgins J.A., Radulovic S., Jaworski D.C., Azad A.F. Acquisition of the cat scratch disease agent Bartonella henselae by cat fleas, J Med Entomol 33, 1996, 490–495. [DOI] [PubMed] [Google Scholar]
  • 21. Bradbury C.A., Lappin M.R. Evaluation of topical application of 10% imidacloprid-1% moxidectin to prevent Bartonella henselae transmission from cat fleas, J Am Vet Med Assoc 236 (8), 2010. Apr, 869–873. [DOI] [PubMed] [Google Scholar]
  • 22. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, MMWR Recomm Rep 58 (RR-4), 2009. Apr 10, 1–20. [PubMed] [Google Scholar]
  • 23. Peters I.R., Helps C.R., Willi B., Hofmann-Lehmann R., Tasker S. The prevalence of three species of feline haemoplasmas in samples submitted to a diagnostics service as determined by three novel real-time duplex PCR assays, Vet Microbiol 126, 2008, 142–150. [DOI] [PubMed] [Google Scholar]
  • 24. Woods J.E., Brewer M.M., Hawley J.R., Wisnewski N., Lappin M.R. Attempted experimental transmission of ‘Candidatus Mycoplasma haemominutum’ and Mycoplasma haemofelis by Ctenocephalides felis , Am J Vet Res 66, 2005, 1008–1012. [DOI] [PubMed] [Google Scholar]
  • 25. Willi B., Boretti F.S., Meli M.L., et al. Real-time PCR investigation of potential vectors, reservoirs and shedding patterns of feline Haemotropic mycoplasmas, Applied Enviro Microbiol 73, 2007, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Dean R.S., Helps C.R., Jones T.J. Gruffydd, Tasker S. Use of real-time PCR to detect Mycoplasma haemofelis and “Candidatus Mycoplasma haemominutum” in the saliva and salivary glands of haemoplasma-infected cats, J Feline Med Surg 10 (4), 2008. Aug, 413–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Willi B., Tasker S., Boretti F.S., et al. Phylogenetic analysis of ‘Candidatus Mycoplasma turicensis’ isolates from pet cats in the United Kingdom, Australia, and South Africa, with analysis of risk factors for infection, J Clin Microbiol 44, 2006, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Simpson K.E., Devine B.C., Gunn-Moore D. Suspected toxoplasma associated myocarditis in a cat, J Feline Med Surg 7, 2005, 203–208. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Feline Medicine and Surgery are provided here courtesy of SAGE Publications

RESOURCES